The GSv9TM Media and Feeds Platform was developed by Lonza specifically for GS-CHO cell lines. The platform complements Lonza’s proprietary GS Gene Expression System® for the production of therapeutic recombinant proteins and monoclonal antibodies.
The new platform incorporates GS-CHO cell culture medium, feed base powders and supplements and is globally manufactured and supplied by our custom media production facilities.
Characteristics of GSv9TM Media and Feeds:
- Highest protein quality with
- low levels of aggregates and fragments, and
- appropriate glycosylation pattern
- Chemically defined and animal component-free (CDACF)
- Developed by Lonza specifically for GS-CHO cell lines
- Increased antibody yield
Contact us at mediasales@lonza.com to discuss your requirements.
